Trademark Overview
On Tuesday, August 27, 2024, a trademark application was filed for ZEQLUMO with the United States Patent and Trademark Office. The USPTO has given the ZEQLUMO trademark a serial number of 98719344. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, August 27, 2024. This trademark is owned by Genzyme Corporation. The ZEQLUMO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases notably lysosomal storage disorders and autosomal dominant polycystic kidney disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections.